Ivermectin, praziquantel, tamiflu, triclosan의 환경위해성평가

• 영문명: Environmental Risk Assessment for Ivermectin, Praziquantel, Tamiflu and Triclosan
• 발행기관: 한국환경보건학회
• 저자명: 류태권(Taekwon Ryu) 김정곤(Jungkon Kim) 김경태(Kyungtae Kim) 이재우(Jaewoo Lee) 김지은(Jieun Kim) 조재구(Jaegu Cho) 윤준헌(Junheon Yoon) 이재안(Jaean Lee) 김필제(Pilje Kim) 류지성(Jisung Ryu)
• 간행물 정보: 『1. 한국환경보건학회지』제44권 제2호, 196~203쪽, 전체 8쪽
• 주제분류: 공학 > 환경공학
• 파일형태: PDF
• 발행일자: 2018.04.30

영문 초록

Objectives: The purpose of this study was to assess environmental risk on the emerging contaminants of concern, such as ivermetin, parziquantel, tamiflu and triclosan. Furthermore, we tried to provide a more efficient management practice and a basis for future studies of risk assessment on those substances. Methods: Predicted no effect concentration (PNEC) and predicted environmental concentration (PEC) were determined through modeling and literature reviews. Environmental risk assessment was evaluated by calculating HQ (hazard quotient) by a comparison of PEC (or measured environmental concentration (MEC)) and PNEC. Results: HQ value of tamiflu calculated from MEC was 1.9E-03. For ivermectin and triclosan, the HQ values were not available because these were not detected in the aquatic environment. The toxicity of ivermectin and triclosan showed a very low value, indicating a high level of HQ. However, praziquantel can be categorized into the material that do not require management since they have less than HQ 1. Conclusion: Based on the results of the initial risk assessment, it is assumed that the ivermectin and triclosan have potential to cause direct adverse effects on the aquatic environment. To conduct an accurate environmental risk assessment, the further study on PEC estimation of such contaminants should be actively carried out.

목차

Ⅰ. 서 론

Ⅱ. 연구방법

Ⅲ. 연구결과 및 고찰

Ⅳ. 결 론

키워드

Environmental risk assessment contaminants of emerging concerns pharmaceuticals personal care products